Replies to post #25260 on Marker Therapeutics Inc (MRKR)

[mikeslife]

Thank you Lady luck

[Lady_luck]

Curious on updates for tonight’s presentation. If anyone has links or updates, please provide.

Thanks!

1014 Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple Myeloma
Program: Oral and Poster Abstracts
Type: Oral
Session: 653. Myeloma: Therapy, excluding Transplantation: Immunotherapy
Hematology Disease Topics & Pathways:
Biological, multiple myeloma, viral, Diseases, Therapies, immunotherapy, Plasma Cell Disorders, Clinically relevant, Lymphoid Malignancies
Monday, December 3, 2018: 7:30 PM